Literature DB >> 23631320

The development and introduction of ballistic protection of the external genitalia and perineum.

Eluned A Lewis1, M A Pigott, A Randall, A E Hepper.   

Abstract

In response to an Urgent Operational Requirement, the UK Ministry of Defence (MoD) investigated, designed, developed, trialled and subsequently fielded a Tiered Pelvic Protection System to service personnel deployed on Operation HERRICK in Afghanistan. An Urgent Statement of User Requirement (USUR) was drafted in order to equip service personnel with protection for the groin, perineum, buttocks and upper thigh areas from the effects of buried Improvised Explosive Devices (IEDs). Injuries to the groin and pelvic area from buried IEDs can have severe physiological and psychological impact; therefore the aim of the pelvic protection was to reduce the number and severity of such injuries and to improve the outcome, both in terms of quality of life of the survivors and increase the chances of survival. The aim of this paper is to outline some of the research and development that contributed to the design(s) of the Tiered Pelvic Protection System; describe the components of, and report the medical success of, the Tiered Pelvic Protection System.

Entities:  

Mesh:

Year:  2013        PMID: 23631320     DOI: 10.1136/jramc-2013-000026

Source DB:  PubMed          Journal:  J R Army Med Corps        ISSN: 0035-8665            Impact factor:   1.285


  2 in total

1.  Synthetic biology for fibres, adhesives and active camouflage materials in protection and aerospace.

Authors:  Aled D Roberts; William Finnigan; Emmanuel Wolde-Michael; Paul Kelly; Jonny J Blaker; Sam Hay; Rainer Breitling; Eriko Takano; Nigel S Scrutton
Journal:  MRS Commun       Date:  2019-04-24       Impact factor: 2.566

2.  Gelatine Backing Affects the Performance of Single-Layer Ballistic-Resistant Materials Against Blast Fragments.

Authors:  Thuy-Tien N Nguyen; George Meek; John Breeze; Spyros D Masouros
Journal:  Front Bioeng Biotechnol       Date:  2020-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.